-
1
-
-
0024269590
-
Effects of tamoxifen and of cytotoxic therapy on mortality in early breast cancer: An overview of 61 randomized trials among 28,896 women
-
Early Breast Cancer Trials Collaborative Group: Effects of tamoxifen and of cytotoxic therapy on mortality in early breast cancer: An overview of 61 randomized trials among 28,896 women. N Engl J Med 319:1681, 1988
-
(1988)
N Engl J Med
, vol.319
, pp. 1681
-
-
-
2
-
-
0026593828
-
Tamoxifen - panacea or Pandora's box?
-
Davidson NE: Tamoxifen - panacea or Pandora's box? N Engl J Med 326:885, 1992
-
(1992)
N Engl J Med
, vol.326
, pp. 885
-
-
Davidson, N.E.1
-
3
-
-
0027955643
-
Effect of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancer
-
Thangaraju M, Kumar K, Gandhirajan R, et al: Effect of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancer. Cancer 73:659, 1994
-
(1994)
Cancer
, vol.73
, pp. 659
-
-
Thangaraju, M.1
Kumar, K.2
Gandhirajan, R.3
-
4
-
-
0024546736
-
Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
-
Forlander T, Cedermark B, Mattsson A, et al: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1:117, 1989
-
(1989)
Lancet
, vol.1
, pp. 117
-
-
Forlander, T.1
Cedermark, B.2
Mattsson, A.3
-
5
-
-
0027412216
-
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients
-
Magriples U, Naftolin F, Schwartz PE, et al: High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11:485, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 485
-
-
Magriples, U.1
Naftolin, F.2
Schwartz, P.E.3
-
6
-
-
0028020104
-
Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features
-
Barakat RR, Wong G, Curtin JP, et al: Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol 55:164, 1994
-
(1994)
Gynecol Oncol
, vol.55
, pp. 164
-
-
Barakat, R.R.1
Wong, G.2
Curtin, J.P.3
-
8
-
-
0024505760
-
Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line)
-
Anzai Y, Holinka CF, Kuramoto H, et al: Stimulatory effects of 4-hydroxytamoxifen on proliferation of human endometrial adenocarcinoma cells (Ishikawa line). Cancer Res 49:2362, 1989
-
(1989)
Cancer Res
, vol.49
, pp. 2362
-
-
Anzai, Y.1
Holinka, C.F.2
Kuramoto, H.3
-
9
-
-
0023915865
-
Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse
-
Gottardia MM, Robinson SP, Satyaswaroop PG, et al: Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Cancer Res 48:812, 1988
-
(1988)
Cancer Res
, vol.48
, pp. 812
-
-
Gottardia, M.M.1
Robinson, S.P.2
Satyaswaroop, P.G.3
-
11
-
-
0024428521
-
Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids
-
Lumsden MA, West CP, Baird DT: Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids. Clin Endocrinol 31:335, 1989
-
(1989)
Clin Endocrinol
, vol.31
, pp. 335
-
-
Lumsden, M.A.1
West, C.P.2
Baird, D.T.3
-
13
-
-
0028361473
-
Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen
-
Ugwumadu AH, Handing K: Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen. Eur J Obstet Gynecol Reprod Biol 54:153, 1994
-
(1994)
Eur J Obstet Gynecol Reprod Biol
, vol.54
, pp. 153
-
-
Ugwumadu, A.H.1
Handing, K.2
-
14
-
-
0029047779
-
Fibroid growth in response to high-dose progestogen
-
Harrison-Woolrych M, Robinson R: Fibroid growth in response to high-dose progestogen. Fertil Steril 64:191, 1995
-
(1995)
Fertil Steril
, vol.64
, pp. 191
-
-
Harrison-Woolrych, M.1
Robinson, R.2
-
15
-
-
0030050436
-
Tamoxifen-induced growth of leiomyomas: A case report
-
Kang J, Baxi L, Heller D: Tamoxifen-induced growth of leiomyomas: A case report. J Reprod Med 41:119, 1996
-
(1996)
J Reprod Med
, vol.41
, pp. 119
-
-
Kang, J.1
Baxi, L.2
Heller, D.3
-
16
-
-
0002616484
-
Does the use of postmenopausal hormone replacement therapy influence the size of uterine leiomyomata? A preliminary report
-
Schwartz LB, Lazer S, Mark M, et al: Does the use of postmenopausal hormone replacement therapy influence the size of uterine leiomyomata? A preliminary report. Menopause: J North Am Menopause Soc, 3:38, 1996
-
(1996)
Menopause: J North Am Menopause Soc
, vol.3
, pp. 38
-
-
Schwartz, L.B.1
Lazer, S.2
Mark, M.3
-
18
-
-
0028921473
-
Progesterone: A critical role in the pathogenesis of uterine myomas
-
Rein MS, Barbieri RL, Friedman AJ: Progesterone: A critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 172:14, 1995
-
(1995)
Am J Obstet Gynecol
, vol.172
, pp. 14
-
-
Rein, M.S.1
Barbieri, R.L.2
Friedman, A.J.3
-
19
-
-
0027981772
-
Two cases of ovarian cysts in postmenopausal patients under antiestrogen treatment
-
Re A, Wierdis T, Tessarolo M, et al: Two cases of ovarian cysts in postmenopausal patients under antiestrogen treatment. Clin Exp Obstet Gynecol 21:221, 1994
-
(1994)
Clin Exp Obstet Gynecol
, vol.21
, pp. 221
-
-
Re, A.1
Wierdis, T.2
Tessarolo, M.3
-
20
-
-
0000445294
-
Ovarian cysts in promenopausal and postmenopausal tamoxifen-treated women with breast cancer
-
Shushan A, Peretz T, Uziely B, et al: Ovarian cysts in promenopausal and postmenopausal tamoxifen-treated women with breast cancer. Am J Obstet Gynecol 175:752, 1996
-
(1996)
Am J Obstet Gynecol
, vol.175
, pp. 752
-
-
Shushan, A.1
Peretz, T.2
Uziely, B.3
|